178 related articles for article (PubMed ID: 24297639)
41. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
Lin L; Hutzen B; Ball S; Foust E; Sobo M; Deangelis S; Pandit B; Friedman L; Li C; Li PK; Fuchs J; Lin J
Cancer Sci; 2009 Sep; 100(9):1719-27. PubMed ID: 19558577
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells.
Valentini A; Conforti F; Crispini A; De Martino A; Condello R; Stellitano C; Rotilio G; Ghedini M; Federici G; Bernardini S; Pucci D
J Med Chem; 2009 Jan; 52(2):484-91. PubMed ID: 19113979
[TBL] [Abstract][Full Text] [Related]
43. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
44. Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one.
Citalingam K; Abas F; Lajis NH; Othman I; Naidu R
Molecules; 2015 Feb; 20(2):3406-30. PubMed ID: 25690296
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
46. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3.
Chendil D; Ranga RS; Meigooni D; Sathishkumar S; Ahmed MM
Oncogene; 2004 Feb; 23(8):1599-607. PubMed ID: 14985701
[TBL] [Abstract][Full Text] [Related]
47. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
48. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
49. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
51. Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR.
Liu T; Chi H; Chen J; Chen C; Huang Y; Xi H; Xue J; Si Y
Gene; 2017 Oct; 631():29-38. PubMed ID: 28843521
[TBL] [Abstract][Full Text] [Related]
52. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
[TBL] [Abstract][Full Text] [Related]
53. Monensin Induces PC-3 Prostate Cancer Cell Apoptosis via ROS Production and Ca2+ Homeostasis Disruption.
Kim SH; Kim KY; Yu SN; Park SG; Yu HS; Seo YK; Ahn SC
Anticancer Res; 2016 Nov; 36(11):5835-5843. PubMed ID: 27793906
[TBL] [Abstract][Full Text] [Related]
54. In Vitro and In Vivo Efficacy Studies of Lavender angustifolia Essential Oil and Its Active Constituents on the Proliferation of Human Prostate Cancer.
Zhao Y; Chen R; Wang Y; Qing C; Wang W; Yang Y
Integr Cancer Ther; 2017 Jun; 16(2):215-226. PubMed ID: 27151584
[TBL] [Abstract][Full Text] [Related]
55. Effects of curcumin analogues for inhibiting human prostate cancer cells and the growth of human PC-3 prostate xenografts in immunodeficient mice.
Zhou DY; Ding N; Van Doren J; Wei XC; Du ZY; Conney AH; Zhang K; Zheng X
Biol Pharm Bull; 2014; 37(6):1029-34. PubMed ID: 24647337
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
57. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.
Zhu M; Zheng Z; Huang J; Ma X; Huang C; Wu R; Li X; Liang Z; Deng F; Wu J; Geng S; Xie C; Zhong C
J Cell Biochem; 2019 Sep; 120(9):15616-15624. PubMed ID: 31042325
[TBL] [Abstract][Full Text] [Related]
58. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
59. Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
Zhang J; Ahn KS; Kim C; Shanmugam MK; Siveen KS; Arfuso F; Samym RP; Deivasigamanim A; Lim LH; Wang L; Goh BC; Kumar AP; Hui KM; Sethi G
Antioxid Redox Signal; 2016 Apr; 24(11):575-89. PubMed ID: 26649526
[TBL] [Abstract][Full Text] [Related]
60. Physapubescin B Exhibits Potent Activity against Human Prostate Cancer In Vitro and In Vivo.
Ding W; Hu Z; Zhang Z; Ma Q; Tang H; Ma Z
J Agric Food Chem; 2015 Nov; 63(43):9504-12. PubMed ID: 26415552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
